For Immediate Release: June 9, 2017
Contact: Mr Benito Novas
info@stemcellsgroup.com
Phone: +1305 560 5337
GLOBAL STEM CELLS GROUP TO ATTEND THE FLORIDA INTERNATIONAL MEDICAL EXPO THIS AUGUST
Florida – Global Stem Cells Group, an international network of stem cell researchers, medical professional, academics, and practicing doctors all working together to foster collaboration with regards to the study of regenerative medicine, this week excitedly announced that their leadership team, along with the executive team from N-Biotek, will be attending this year’s Florida International Medication Expo (FIME), the largest medical trade fair across the Americas today.
N-Biotek, a main manufacturer of biomedical and lab equipment in the world through their own patented technique, will be joining Global Stem Cells Group for the 3-day event set to kick off August 8, 2017 at the Orange County Convention Center in Orlando, Florida.
“As the biggest trade fair across the Americas, we felt it was incredibly important to attend this event for unmatched communication and collaboration with all professionals in attendance,” said Mr Novas, Founder and Owner of Global Stem Cells Group. “By attending it with our strategic partner N-Biotek, we hope to foster discussion surrounding the production of their stem cell products, as well as how we can all come together for the spread of regenerative medicine today.”
Now in its 27th year, FIME will welcome over 22,00 medical and healthcare trade professionals from North, Central, and South America, as well as from across the globe. Over 1,500 national and international companies showcasing new and refurbished medical and hospital equipment, technology, products, and supplies will also be present.
In addition to the normal exhibitor stands and speakers, FIME 2017 will introduce a dedicated wall at the exhibition for businesses to publicize the different products and services they are after. The event will also offer 3 multi-disciplinary conference tracks in the field of laboratory medicine and diagnostics, focusing specifically on Clinical Microbiology, Point of Care Testing (POCT), and Haematology.
“We are inviting all of our partners and clients to come visit us at this monumental event,” said Mr Benito Novas. “By mentioning our name at the door, we can get in any client for free to experience the event with us and N-Biotek. Spread the word on our upcoming attendance at this year’s FIME event, and head on over to our website to learn more about our advancements in stem cell medicine today.”
Visitor, as well as exhibitor, registration is now open for FIME 2017.
For more information about the event, visit: https://www.fimeshow.com/en/overview.html.
For free access contact us at info@stemcellsgroup.com

For Immediate Release: June 9, 2017
Contact: Mr Benito Novas
info@stemcellsgroup.com
Phone + 305 560 5337
GLOBAL STEM CELLS GROUP TO LAUNCH FDA-REGISTERED SVF KITS AT THIS YEAR’S FIME EVENT
Orlando, FL – Global Stem Cells Group, an international network of stem cell medicine students, academics, practitioners, and researchers all passionate about sharing their findings and advancements with regards to the potential of regenerative medicine, this week announced they will be launching their FDA-Registered SVF kits at this year’s Florida International Medical Expo (FIME).
With the event now in its 27th year, FIME is the largest medical trade fair across the Americas. As such, Global Stem Cells Group felt it is the perfect place to launch their SVF Kit, which is both FDA-Register and CE-certified. Also known as the STEMPIA Kit, these kits are being used in clinical procedures like intra-articular injections, cosmetic surgery, acne scarring, dermal injections, stem cell enriched fat transfers, chronic ulcers, and other conditions today.
“These one-of-a-kind kits are built with N-Biotek technology that has been proven and verified in multiple patient outcomes,” said Mr. Benito Novas, Founder and Owner of Global Stem Cells Group. “With FIME being such a remarkable international gathering among medical personnel, we are excited to be introducing these kits to all event attendees.”
The SVF Kits are sterilized ADSC isolation close systems with proprietary technology that guarantees the highest yield and viability for minimizing contamination.
To be introduced at FIME, the three-day event will host an exhibition of over 22,000 medical and healthcare trade professionals from North, Central, and South America. Additionally, there will be 1,500+ national and international companies showcasing new and refurbished medical and hospital equipment, technology, products, and supplies – Global Stem Cells Group being one of them.
“Spread the word on the availability of our new kits at this year’s FIME event, kicking off August 8, 2017,” said Mr. Novas.

For Immediate Release: May 17, 2017
Contact: Benito Novas
info@stemcellsgrou.com
+1305 560 5337
STEM CELLS TRAINING LAUNCHES ONSITE MEDICAL TRAINING WITH FIRST COURSE IN NEW YORK THIS JUNE 2ND
Jericho, NY – Stem Cells Training, a subsidiary entity out of the Stem Cells Group, a global network of stem cells related physicians, doctors, researchers, and innovators passionate about furthering the development of regenerative medicine, this week excitedly announced they are hosting their first Stem Cell Training program designed for growing medical practices right in the student’s own facility. Called the ‘Grow Your Medical Practice Program,’ Stem Cells Training will be administered at the Sadhna Center in Jericho, New York on June 2nd and 3rd.
Borne from a passion for providing a valuable, immersive training experience to doctors around the world, Stem Cells Training will bring all the necessary equipment and supplies for showing students how to properly set up stem cell treatment right in their own office.
“This course takes a highly visual and interactive angle, which provides trainers with the ability to teach reintegration and procedural techniques on live patients using different protocols for isolating stem cells – right from their own medical establishment,” said Mr Benito Novas, Founder and Owner of Stem Cells Training. “We understand that learning something in the class room is one thing; seeing it come to life in one’s own medical facility is totally another thing.”
The course will provide live demonstrations of the extraction, isolation, and application of PRP, Adipose, and Bone Marrow Stem Cells for all participants. All students will have hands-on training experience, participating in different medical case treatments, supervised by the Stem Cells Training specialists.
Sadhna Center is headed by Dr. Vika Varma, an internationally regarded practitioner who has trained at some of the best teaching hospitals in the U.S., including Mt. Sinai School of Medicine, Hahnemann University, and North Shore University Hospital where he currently works as an attending physician.
“After 15-years of practicing anti-aging medicine, I am eager to learn more about how, through regenerative medicine, we can offer the very best to our clients here at the Sadhna Center,” said Dr. Varma. “We look forward to our collaborative, onsite training with Stem Cell Training this June.”
Afterwards, students will have access to high-resolution step-by-step videos of procedures for future reference and recall.
Each Stem Cells Training onsite program will be custom tailored to the client, permitting up to 10 trainees per program.
“This training is a new opportunity we are offering doctors around the world who are interested in receiving expert training for their whole staff in their own personal medical facilities,” said Mr Novas.
For more information, visit: https://stemcellsgroup.cl/sct/onsitetraining

For Immediate Release: April 27, 2017
Contact: Mr Benito Novas
info@stemcellsgroup.com
+1305 560 5337
STEM CELL CENTER ANNOUNCES OPENING OF 25TH LOCATION IN MEXICO CITY
Mexico City, Mexico – The Stem Cell Center, a subsidiary of the Global Stem Cells Group that works to develop and oversee stem cell and regenerative medicine clinics set up in every major international city today, this week excitedly announced they are expanding into Mexico with their 25th office location to be officially unveiled in Mexico City.
To be an expert facility that is a reference to all regenerative medicine practitioners in Mexico City, Medical Director Dr. Jose Arrieta will oversee the new Stem Cell Center. Dr. Arrieta is a specialist Otorhinolaryngology and Head and Neck surgeon, member of the Mexican Council of Otorhinolaryngology and Head and Neck Surgery since 1984, and is presently an Associate Postgraduate Professor at the National Autonomous University of Mexico in Mexico City.
“Our goal is to have our office be a universal standard of regenerative medicine for all doctors in the greater Mexico City Region,” said Mr. Benito Novas, Founder and Owner of the Stem Cells Group. “Doctors are welcome to bring their patients to our medicinal facility, where we will have high ranking technology and qualified professionals ready to support the Mexican doctors and patients.”
The new Stem Cell Center is set up with booths so the facility is able to accommodate multiple doctors and patients at a time. The Stem Cell Group is hoping this universal access to regenerative medicine support will encourage local doctors to explore the potential of stem cells with regards to their respective fields.
“I look forward to managing and spread awareness on this new revolutionary clinic for doctors near and far to its central Mexico City location,” said Dr. Arrieta.
For more information, visit: http://stemcellcenter.net/.

For Immediate Release: April 24, 2017
Contact: Benito Novas
info@stemcellsgroup.com
+305 560 5337
GLOBAL STEM CELLS GROUP AND WESTMINSTER UNIVERSITY IN KOREA AWARD CERTIFICATES TO REGENERATIVE MEDICINE STUDENTS
Korea – Global Stem Cells Group, an international network comprised of physicians, doctors, researchers, students, and educators all passionate about researching, discovering, and sharing new information with regards to the stem cell industry and regenerative medicinal capabilities today, this last week, at the completion of their regenerative stem cell science program in Korea, teamed up with the Westminster University in Korea to award students with course completion certificates.
Distributed to the students who completed the comprehensive Stem Cells Fellowship program with a thorough understanding of regenerative medicine in our world today, the certificates were given out during a completion ceremony in which the president of the Global Stem Cells Group, Benito Novas, and the president of the Westminster Graduate University, Ph.D. Paul In Chan Chung, were in attendance.
Dr. Paul In Chan Chung personally handed each student his or her certificate.
“This was a monumental recognition ceremony for students who have gone above and beyond with regards our regenerative medicine lab-setting course,” said Novas. “We need more people to be committed to furthering the effects of stem cell medicine, and this batch of students is well on their way to contributing to the future of the industry.”
Global Stem Cells Group is the only regenerative medicine training business to have a University endorsement for teaching and practicing regenerative medicine with students. After the incredible success of the past course, Dr. Paul In Chan Chun announced they will continue to offer this kind of Fellowship Program for students at the university next summer. The university, in conjunction with the Global Stem Cells Group, will be announced the official date shortly.
“We are honored to be offering such cutting edge education for our students here at the Westminster University in Korea,” said Dr. Paul In Chan Chun. “Global Stem Cells Group is a full-service educational institution that provides expert training, onsite monitoring, and education-related resources to facilities across the world. After the success of this past Fellowship, it was a no-brainer to discuss offering it again sometime next summer.”
Students in the course learned about cell culture, plating, trypsinization, harvesting, and cryopreservation. They applied quality control tests that included cell count, viability, flow cytometry, endotoxin, mycoplasma, and sterility.
Global Stem Cell Group and its subsidiary institutions are adept in stem cell research, patient applications, and student education. Through their off-branch entities, they are able to influence every aspect of the regenerative medicine industry today.
For more information, visit: http://stemcellsacademy.com/

For Immediate Release: April 15, 2017
Contact: Benito Novas,
info@stemcellsgroup.com
+1305 560 5337
GLOBAL STEM CELLS GROUP TO LAUNCH KFDA-CERTIFIED SVF KIT
Global Stem Cells Group, an international network of stem cells based doctors, researchers, physicians, and laboratory specialists all passionate about furthering the effectiveness and availability of stem cells, this week proudly announced they are launching their new SVF Kit, which is both KFDA-certified and CE-certified.
Also known as the STEMPIA Kit, it is presently being used in clinic procedures like intra-articular injections, cosmetic surgery, acne scarring, dermal injections, stem cell enriched fat transfers, wounds, chronic ulcers, and other chronic conditions today.
“Our SVF Kits are built with N Bioteck technology that has been independently reviewed and proven in various critical performance points that make a different in patient outcomes,” said Mr Benito Novas, Founder and Owner of Global Stem Cells Group. “We are incredibly excited to be offering this kind of resourcefulness on a global scale to all of our participating physicians and interested doctors.”
The SVF Kits are sterilized ADSC isolation closed systems with proprietary technology that guarantees the highest yield and viability for minimizing the risk of contamination. Additionally, the kits come with a PRP- PBSC device with vortex engineering methods to minimize platelet loss. They are laboratory disposable, and have an enzymatic component for the most accurate results possible.
Overall, the kits provide a closed, sterile, and safe isolation process for anyone who uses them.
“By using our SVF Kits, doctors can rest assured they are reducing the donor variations possible while eliminating the risk for contaminations at every step of the process,” said Mr Novas. “They curtail any unpredictability in the stem material, as well as the outcomes at the end of the experiments. Spread the word on the official availability of our new kits, and head on over to our website today to learn more about our global network.”
For more information, contact us at info@stemcellsgroup.com

For Immediate Release: April 13, 2017
Contact: Benito Novas
info@stemcellsgroup.com
+1 305 560 5337
GLOBAL STEM CELLS GROUP HOSTS SECOND EDITION KOREAN DIPLOMAT STEM CELL TRAINING
Korea – Global Stem Cells Group, a full-service, educationally based international network of doctors, teachers, researchers, and physicians all actively practicing and advancing the study of stem cells in a variety of medical fields, this week hosted the second edition of its Korean Diplomat Stem Cell Training after an overwhelming response to its first edition.
Running from April 9 to the 15, 2017, the team is there now with doctors participating in the course from around the world, including members from Colombia, Mexico, the U.S., Korea, and more.
“We are the only regenerative medicine training business that is able to offer this kind of hands-on education in our own, fully-functioning laboratory,” said Dr. Benito Novas, Founder and Owner of Stem Cell Training. “We understand that this kind of medical teaching requires an immersive learning environment, which is why we work hard to provide the most realistic educational immersion possible.”
During the course this week, doctors are observing live, hands-on surgeries and experiences with patients from the perspective of participating faculty. These doctors are being trained in a laboratory setting with translational practical activities for developing life-changing skills. Lastly, to ensure the best possible experience, Stem Cells Group has multiple faculty on staff so each doctor is provided with unwavering medical oversight.
“After the speed at which the first edition of our Korean course filled, we knew there needed to be a second one,” said Novas. “And now, after witnessing our second batch of doctors this week, I can confidently say we will be hosting many more of these training sessions in the future.”
This one-week Diplomatic Cell Therapy and Tissue Engineering course will provide certification by the Global Stem Cells Group, N-Biotek, and the President of the University of Westminster Graduate to the participating students.
For more information, visit: http://stemcellsacademy.com/.

For Immediate Release: April 9, 2017
Contact: Benito Novas
info@stemcellsgroup.com
+305 560 5337
GLOBAL STEM CELLS MEMBER, SILVINA PASTRANA, TO BE FEATURED SPEAKER AT ‘JORNADAS INTERNACIONALES DE MEDICINA ESTETICA Y ANTI AGE’
Rosario, Argentina – Global Stem Cells Group, a global network of physicians, doctors, researchers, and educators all passionate about stem cell research and implementation through clinical trials, collaboration, and communication, this week excitedly announced one of their esteemed faculty, Silvina Pastrana, will be the featured speaker at this year’s Jornadas Intrenacionales de Medicina Estetica y Anti Age on June 30, 2017 in Rosario, Argentina.
As the surgeon and medical director of the Stem Cell Center Buenos Aires and Regentherapy Puerto Madero, Pastrana, an Argentinian doctor with a degree from the University of Buenos Aires, was selected for her expertise in Regenerative Medicine.
“As an integral part of the Stem Cells organization here in Buenos Aires, I am incredibly humbled and exciting to be representing my network up on stage this May,” said Pastrana.
Additionally, Damian Siano, another Global Stem Cells Group affiliate, will also be speaking about his advancements in Traumatology and Orthopedics. As an Argentinian doctor who graduated from the Universidad de Buenos Aires in 1994, he is today a worldwide specialist in Sports Medicine and Pain Management.
“We are excited to have two of our faculty members present at such a monumental international event held every year in Argentina,” said Benito Novas, Founder and Owner of Global Stem Cells Group. “We look forward to the medical collaboration and networking this June.”
Following this year’s event, Global Stem Cells Group will be hosting a Stem Cells Training Course in Buenos Aires on July 1 and 2. The hands-on training will include concepts of cellular and molecular biology, techniques of extraction and insulation of derived cells of adipose tissue, extraction of bone marrow cells, and more.
For more information, or to sign up today, visit: https://cursocelulasmadre.com/entrenamiento-argentina-programa/

After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto. With the assistance of more than 1500 physicians and surgeons from around the globe, the conference’s focus was to grow a global understanding of the importance of the aesthetic modalities in plastic and reconstructive surgery and the applications of cellular and regenerative medicine in this field.
The Congress brought together an expert panel for a series of lectures and discussions that hope to provide solutions and create new techniques in the coming years to be applied in plastic and reconstructive surgery. Influential scientific and clinical experts stood together and evaluated the state of research and clinical application.
The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka.  Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells. Yamanaka addressed among other things the importance of the regenerative medicine field opening a new frontier for the treatment of chronic degenerative conditions.
“We are excited to have attended the ISAPS conference once more. Our goal, as always, is to promote scientific training for physicians and research in stem cell technology that we hope will contribute to the global discussion on how these therapies can advance human health and longevity” says Benito Novas, founder and CEO.
Mr. Sanguk Ra, Business Director of N-Biotek, a biotechnology added ;”these are very exciting times, we see more and more physicians getting involved in regenerative medicine, and that of course puts more pressure on the scientists to help advance the field”
Both companies, as leaders of the industry, launched their new Turnkey Solution, a compact and cohesive laboratory as a concept for physicians’ offices, and the new Progenikine Kit, an enzyme based closed system for isolation of adipose derived stem cells.  To learn more, visit the Global Stem Cells Group website, www.stemcellsgroup.com.
About Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.  Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based  mission, the result is a global network of state-of-the-art stem cell treatments.

On the 28th of September 2016, Global Stem Cells Group successfully hosted its 3rd annual International Stem Cells and Regenerative medicine symposium in Buenos Aires Argentina. This International Stem Cells and Regenerative medicine symposium was dignified by the participation of the most renowned and experienced physicians on stem cell and regenerative medicine from Latin America and Europe.
The symposium was also graced by an online participation of several physicians through online streaming and a speaker lineup which included highly coveted personalities from the areas of scientific research, clinical research and regulatory world. This team of prominent and talented specialists in medical research and international stem cell used the forum to share the recent discoveries and advancements in scientific research and medical science.
During the inauguration of the symposium, Global Stem Cells Group honored Dr. Joseph Purita for his lifetime achievements and contributions to the cellular and regenerative medicine and his guide to the Global Stem Cells Group faculty from its inception. Dr. Purita is a world renowned orthopedic surgeon and the pioneer in laser techniques in orthopedic surgery and the application of stem cells and PRP therapies for orthopedic injuries and diseases.
After the symposium, Stem Cell Training the group’s arm for physician education hosted a full enrollment workshop where several physicians from Latin America and Europe received hands on training on isolation and reintegration of adult stem cells, use of peptides and cellular secretions and orthomolecular interventions. The physicians were trained on global skills and capabilities required for the treatment of patients in the course of their medical practices and for career development.
To learn more about the 3rd Annual International Symposium on Stem Cells and Regenerative Medicine, visit the Global Stem Cells Group website, or email bnovas@stemcellsgroup.com, or call 305-560-5337.
About Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.